Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Lumos Diagnostics launches U.S. pediatric study for FebriDx® rapid test to reduce unnecessary antibiotics.
Lumos Diagnostics has launched a U.S. pediatric study for its FebriDx® rapid test to assess its accuracy in distinguishing viral and bacterial infections in children, supported by BARDA.
The CLIA-waived test aims to reduce unnecessary antibiotic use.
Meanwhile, American Uranium began drilling at its Lo Herma ISR uranium project in Wyoming to expand its 8.57-million-pound resource, with an interim estimate expected in early 2026.
Polarean Imaging is reviewing its future, including a potential exit from the AIM exchange, citing low trading volume and undervaluation.
5 Articles
Lumos Diagnostics lanza un estudio pediátrico estadounidense para la prueba rápida FebriDx® para reducir los antibióticos innecesarios.